A nuclear medicine procedure during which a sealed radioactive source is implanted directly into a person being treated for cancer (usually of the mouth, breast, lung, prostate, ovaries, or uterus). The radioactive implant may be temporary or permanent, and the radiation attacks the tumor as long as the device remains in place. Brachytherapy uses radioisotopes, such as iridium-192 or iodine-125, which are regulated by the NRC and its Agreement States. For additional information, see Brachytherapy.
Page Last Reviewed/Updated Tuesday, March 09, 2021